Will an mRNA treatment that repairs heart attack damage reach patients within 10 years?
Cambridge scientists used a short-lived mRNA therapy to 'reawaken' heart muscle cells in mice after a heart attack, improving how much blood the heart pumped by about 10 percent. It's an early animal study, but heart muscle normally can't repair itself. How soon could this help people?